Drug trial investigators asked to declare financial interestsBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7187.831 (Published 27 March 1999) Cite this as: BMJ 1999;318:831
- Annabel Ferriman
Doctors and scientists who take part in UK clinical trials of new drugs which may later be licensed in the United States will have to declare any financial interests under new regulations issued by the United States Food and Drug Administration (FDA).
The Association of the British Pharmaceutical Industry (ABPI) has told its members, …
Log in using your username and password
Log in through your institution
Sign up for a free trial